Leaders in Preclinical Drug Safety and Development Consulting

Experience and expertise have made Hugh E. Black & Associates leaders in preclinical drug safety and development consulting. Established in 1994, led by Dr. Black’s senior management and staffed by a small nucleus of individuals with years of senior industrial and regulatory experience, Hugh E. Black & Associates has assisted clients in all aspects of preclinical research, safety and metabolism. Our background and experience spans both industry and FDA regulatory process, offering our clients the sound advice and assistance that results in successful development programs for new medicines or medical devices.

pharmaceutical development consulting image

Learn more about our pharmaceutical development expertise Hugh E. Black & Associates, experts in preclinical drug development

Menu of Services

News & Innovation

LINZESS™ (linaclotide) receives FDA approval...more...

Eylea (afilbercept) injection receives FDA approval...more...

KRYSTEXXA (pegloticase) receives FDA approval ...more...

The Pulse of Pharma

Presentations, opinions and analyses exploring the world of pharmaceutical product development and nonclinical research...
overview of the pharmaceutical industry image
overview of the pharmaceutical industry image